OGN - Organon & Co.

Over the past 90 days, insiders at Organon & Co. (OGN) have been net sellers, shedding 14,761 shares worth roughly $200K on balance.

OGN sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
CFO	Walsh Matthew M	212.7K	$1.21M	-
CEO	Morrissey Joseph T. Jr.	123.1K	-	-
Other	Stahler Rachel A	116.1K	-	-
Other	Falcione Aaron	101.4K	-	-
Other	Weaver Kirke	92.6K	-	-

Buys and sells only

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 5, 2026	Drinane Juliana Papa	Head of Mfg &Supply	Sell	14,761	$13.57	$200,306.77	-44.4%	-	-
May 6, 2026	Holzbaur Lynette	SVP and Corporate Controller	Buy	26,448	$13.35	$353,080.40	+100.2%	+1.1%	-
Nov 12, 2025	Cox Carrie Smith51	Executive Chair	Buy	65,400	$7.67	$501,755.34	+524.5%	+1.3%	-
May 14, 2025	Cox Carrie Smith51	Director	Buy	12,469	$8.07	$100,591.16	New	+12.6%	-
May 7, 2025	Falcione Aaron	Chief Human Resources Officer	Buy	5,500	$8.77	$48,235.00	+9.6%	-4.1%	-
May 6, 2025	Weaver Kirke	Gen. Counsel &Corp. Secretary	Buy	8,045	$9.21	$74,054.23	+18.1%	+5.9%	+45.6%
May 6, 2025	Karp Daniel	Executive VP, Corp. Dev.	Buy	3,500	$8.24	$28,828.10	+8.1%	+5.9%	+45.6%
May 5, 2025	Walsh Matthew M	Chief Financial Officer	Buy	11,400	$8.82	$100,548.00	+8.6%	+10.9%	+52.4%
May 5, 2025	Ali Kevin	Chief Executive Officer	Buy	34,000	$8.81	$299,370.00	+13.7%	+10.9%	+52.4%
Feb 22, 2024	Weaver Kirke	Gen. Counsel &Corp. Secretary	Buy	2,720	$18.36	$49,938.93	+21.8%	+18.4%	-16.5%